15 results on '"Marchetti, Marcello"'
Search Results
2. Multisession radiosurgery for grade 2 (WHO), high risk meningiomas. A phase II clinical trial.
- Author
-
Marchetti, Marcello, Pinzi, Valentina, Iezzoni, Cecilia, Morlino, Sara, Tramacere, Irene, De Martin, Elena, Cane, Irene, and Fariselli, Laura
- Abstract
Purpose: Patients suffering from recurrent and residual grade 2 (WHO) meningiomas after subtotal excision should be considered as high-risk groups with an uncertain prognosis. Adjuvant radiotherapy seems to be the best approach to reduce disease progression. The primary aim of this phase II explorative, monocentric, single arm study was to evaluate the safety of adjuvant multisession radiosurgery (mRS) in this group of patients; the efficacy in terms of tumour local control was the secondary endpoint. Methods: Patients recruited from April 2017 to May 2019 were over 18 years old, had a histologically-documented intracranial recurrent or residual Grade 2 meningioma (WHO 2016) and a KPS > 70. Patients with NF2, concomitant neoplasm or pregnancy were excluded. Descriptive statistics were provided for categorical variables. Progression free survival (PFS) was modelled using the Kaplan–Meier method. Results: Twenty-four patients were enrolled. All 24 patients underwent mRS: twenty-two patients received 28 Gy in 4 fractions, 2 patients received 24 Gy in 4 Treatment related adverse events (CTCAE 4.3) were limited to grade 2 in 1 patient (4.1%). At a median follow-up of 28 months, 8 patients (33.3%) had disease progression, either out-of-field or infield, compared with the planning target volume. Considering both infield and out-of-field progressions, 3-year PFS was 47% (95% confidence interval, CI, 22–69%); considering only the infield ones, 3-year PFS was 86% (95% CI 55–96%), and local control at last follow-up was 92%. Conclusion: mRS provides good local control of the tumour volume (TV) and is associated with a low rate of toxicity. These results call for further investigation to confirm favourable outcomes in patients with high-risk meningioma. Trial information: NCT05081908, October 18, 2021, retrospectively registered. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
3. Multisession radiosurgery for perioptic meningiomas: medium-to-long term results from a CyberKnife cooperative study.
- Author
-
Marchetti, Marcello, Conti, Alfredo, Beltramo, Giancarlo, Pinzi, Valentina, Pontoriero, Antonio, Tramacere, Irene, Senger, Carolin, Pergolizzi, Stefano, and Fariselli, Laura
- Abstract
Purpose: Most recent literature has confirmed the efficacy of single-session radiosurgery (sRS) in the treatment of intracranial meningioma. Unfortunately, sRS is not always applicable due to large tumor volume and the proximity of the tumor to critical structures. When sRS is not recommended, multi-session radiosurgery (mRS) can be the solution. The best treatment schedule for mRS, however, is not well established. The aim of the present retrospective study is to validate the effectiveness of one approach, 25 Gy delivered in 5 fractions in 5 consecutive days, to treat skull base meningiomas. Methods: This is a retrospective multicenter study. Patients with an anterior or a medium skull base meningioma that could not be treated by sRS due to large volume or proximity to the anterior optic pathways (AOPs) underwent 5-fraction mRS. Only patients with at least 36 months follow-up were included in the analysis. Local control and visual outcomes were investigated. Results: One-hundred-sixty-seven patients were included in the analysis. One-hundred-one patients underwent RS as a primary indication and 66 were treated after a previous surgery. The median follow-up period was 51 months (range 36–129 months). Progression-free survival at 3, 5 and 8 years were, respectively, 98%, 94% and 90%. Excluding the progressive disease patients, the visual worsening rate was 3.7%. The 42% of the patients with a pre-treatment visual deficit experienced improvement in vision. Conclusion: 25 Gy delivered in 5 fractions is an effective modality for meningiomas that are near the AOP or are too large to be treated by sRS. The treatment schedule controlled the tumors while sparing visual function. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
4. Radiosurgery for trigeminal neuralgia: the state of art.
- Author
-
Marchetti, Marcello, Pinzi, Valentina, De Martin, Elena, Ghielmetti, Francesco, and Fariselli, Laura
- Subjects
- *
RADIOSURGERY , *FACIAL pain , *TRIGEMINAL neuralgia , *ART & state , *ANALGESIA , *THERAPEUTICS , *PATIENT selection - Abstract
The trigeminal neuralgia (TN) is a chronic, episodic, and disabling facial pain syndrome. It is a relatively rare disorder. Despite this, because of the intensity of the pain, TN may have a dramatic impact for many patients. Fortunately, most of the patients may obtain a good pain relief simply by taking drugs. Historically, the surgical approaches represent a true treatment paradigm for all the drug-resistant TN. In this context, radiosurgery (RS) is a relatively new treatment modality. The effectiveness and safety of radiosurgery are today widely accepted and the technique can be proposed to many patients which suffer from a drug-resistant TN. This is true especially when the patients are less than ideal candidates for an open surgery, or for elderly ones, when a clear neuro-vascular conflict is not evident. The present review provides a concise analysis of the actual indications for radiosurgery, as well as the most acknowledged prognostic factors. The pathogenesis of TN and the rationale for the RS efficacy are also investigated and described. Some technical aspects including the target selection and the prescription doses, which have widely changed in time, are depicted. In conclusion, the present review supports the idea that TN is a complex disease and radiosurgery represents an effective and relatively new treatment modality, which enriches the treatment armamentarium for these unfortunate patients. To optimize the RS results, a correct patient selection has to be performed. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
5. Differentiating brain radionecrosis from tumour recurrence: a role for contrast-enhanced ultrasound?
- Author
-
Mattei, Luca, Prada, Francesco, Marchetti, Marcello, Gaviani, Paola, and DiMeco, Francesco
- Subjects
BRAIN diseases ,BRAIN tumors ,RADIOTHERAPY ,ULTRASONIC imaging ,ELECTROTHERAPEUTICS - Abstract
Differentiating radionecrosis from tumour recurrence is a major issue in neuro-oncology. Conventional imaging is far from being validated as an alternative to histological assessment. We report the case of a patient operated on for suspected recurrence of brain metastasis 9 months after cyberknife radiosurgery. While magnetic resonance imaging showed strong enhancement of the lesion, intraoperative contrast-enhanced ultrasonography (CEUS) surprisingly did not-different from what is expected for brain metastases. Histopathological examination documented radionecrosis. For the first time, we describe radionecrosis with CEUS; further investigation is needed; however, the lack of enhancement could represent an important hallmark in differential diagnosis with neoplastic tissue. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
6. Treatments of glossopharyngeal neuralgia: towards standard procedures.
- Author
-
Franzini, Andrea, Messina, Giuseppe, Franzini, Angelo, Marchetti, Marcello, Ferroli, Paolo, Fariselli, Laura, and Broggi, Giovanni
- Subjects
FACIAL pain ,FACE diseases ,GLOSSOPHARYNGEAL nerve ,NEURALGIA ,PAIN ,THERAPEUTICS - Abstract
The degree of disability due to glossopharyngeal neuralgia (GN) refractory to conservative treatments justifies surgical procedures as second-line treatments. Since the first description of this facial pain disorders, many surgical options have been described either via a percutaneous or an open surgical way. Actually, when a neurovascular conflict on root entry zone (REZ) or cisternal portion of the ninth and tenth cranial nerves is identified, microvascular decompression (MVD) is the first surgical option to consider. Many studies have demonstrated its efficacy and safety for the treatment of GN. Recently, stereotactic radiosurgery has gained space in the treatment of selected cases of GN. We provide an overview of the surgical procedures for the treatment of GN and of our own experience. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
7. Radiosurgery reirradiation for high-grade glioma recurrence: a retrospective analysis.
- Author
-
Pinzi, Valentina, Orsi, Chiara, Marchetti, Marcello, Milanesi, Ida, Bianchi, Livia, DiMeco, Francesco, Cuccarini, Valeria, Farinotti, Mariangela, Ferroli, Paolo, Finocchiaro, Gaetano, Franzini, Angelo, Fumagalli, MariaLuisa, Silvani, Antonio, and Fariselli, Laura
- Subjects
GLIOMA treatment ,GLIOMAS ,RADIOSURGERY ,CANCER relapse ,RETROSPECTIVE studies ,RADIOTHERAPY ,PATIENTS - Abstract
Despite various treatment strategies being available, recurrent high-grade gliomas (r-HGG) are difficult to manage. To obtain local control, radiosurgery (SRS) reirradiation has been considered as potential treatment. In the present study, a retrospective analysis was performed on r-HGG patients treated with salvage single- (s-SRS) or multi-fraction SRS (m-SRS). The aim of this study was to evaluate the effectiveness of salvage SRS in terms of overall survival (OS); toxicity was analyzed as well. Between 2004 May and 2011 December, 128 r-HGG patients (161 lesions) treated with CyberKnife SRS reirradiation were retrospectively analyzed. Toxicity was graded according to Radiation Therapy Oncology Group and by Common Terminology Criteria for Adverse Events v.3 criteria. OS from the diagnosis date and OS from reirradiation were estimated using the Kaplan-Meier method. Median follow-up was 9 months (range 15 days-82 months). All patients completed SRS without high-grade toxicity. Radiation necrosis was observed in seven patients (6 %) with large volume lesions. The median survival from initial diagnosis was 32 months. The 1-, 2-, and 3-years survival rates from diagnosis were 95, 62, and 45 % respectively. Median survival following SRS was 11.5 months. The 1-, 2-, and 3-years survival rate following SRS was 48, 20, and 17 % respectively. On multivariate analysis, age <40 years, salvage surgery before SRS, and other post-SRS therapies (second-line chemotherapy and/or surgery) were found to significantly improve survival ( p = 0.03). SRS represents a safe and feasible option to treat r-HGG patients with low complication rates and potential survival benefit. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
8. The role of radiosurgery in trigeminal neuralgia.
- Author
-
Fariselli, Laura, Ghielmetti, Francesco, Bosetti, Davide, Franzini, Angelo, and Marchetti, Marcello
- Subjects
TRIGEMINAL neuralgia ,FACIAL pain ,NEURALGIA ,TRIGEMINAL nerve diseases ,RADIOSURGERY - Abstract
A short review of clinical use of radiosurgery in trigeminal neuralgia is offered. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
9. Intradural extramedullary benign spinal lesions radiosurgery. Medium- to long-term results from a single institution experience.
- Author
-
Marchetti, Marcello, Martin, Elena, Milanesi, Ida, and Fariselli, Laura
- Subjects
- *
SPINAL cord surgery , *RADIOSURGERY , *NEUROFIBROMA , *SURGICAL excision ,TUMOR surgery - Abstract
Background: Surgery represents the first-choice treatment for spinal intradural tumours. On the other hand, whether it is most appropriate in the setting of recurrences, residual or multiple lesions remains an open question. Moreover, some patients are less than ideal candidates for surgery. In this study we report about our own radiosurgery experience in the treatment of benign intradural extramedullary tumours of the spine. Methods: In our study we analyzed the outcomes for 18 patients (21 lesions) treated for benign intradural extramedullary lesions, with a minimum follow-up period of 32 months. The lesions included 11 meningiomas, 9 schwannomas and 1 neurofibroma. Results: The mean follow-up was 43 months (32-73 months). The median tumour volume was 2 cc (0.2-17.7 cc). Eleven lesions underwent single-fraction treatment (mean prescribed dose ranging from 10 to 13 Gy). The others received a multisession radiosurgery treatment (4-6 fractions) with a mean prescription dose ranging from 18.5 to 25 Gy. The maximum dose to the spinal cord ranged from 9.2 to 26 Gy. During the follow-up period, none of the lesions showed radiological evidence of progression. Neurological status was preserved or improved and no permanent sequelae were observed. Significant and durable pain relief was observed. Conclusions: Although surgical excision remains the primary treatment option for most intradural tumours, radiosurgery offers a real alternative therapeutic modality, especially in case of recurrent and residual lesions or when surgery is contraindicated. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
10. Hypofractionated stereotactic radiotherapy for oligometastases in the brain: a single-institution experience.
- Author
-
Marchetti, Marcello, Milanesi, Ida, Falcone, Chiara, Santis, Michela, Fumagalli, Luisa, Brait, Lorenzo, Bianchi, Livia, and Fariselli, Laura
- Subjects
- *
STEREOTAXIC techniques , *BRAIN tumors , *FOLLOW-up studies (Medicine) , *CANCER radiotherapy , *NEUROTOXICOLOGY , *CANCER invasiveness , *ADJUVANT treatment of cancer , *NEURORADIOLOGY - Abstract
The treatment of brain metastases is changing. Many different radiotherapy options are now available and under clinical evaluation. As part of this effort, we retrospectively evaluated the efficacy and toxicity of hypofractionated stereotactic radiotherapy (HSRT) in patients with up to three brain metastases. Sixty-five patients with 81 lesions were treated with hypofractionated radiotherapy. Median dose was 24 Gy in three fractions. Median follow-up was 24.6 months. Actuarial tumour control was 75 and 45% at 9 months and 24 months after treatment, respectively. Median survival time was 7.5 months, and 32% of the patients died from brain tumour progression. Actuarial overall survival was 75% at 3 months and 25% at 12 months. Recursive partitioning analysis class was the only significant prognostic factor. Neoadjuvant whole-brain radiotherapy (in 29 patients) had no impact on survival or local control. Neurological status improved in 42 patients (65%). Adverse events were rare and usually mild. This experience suggests HSRT should be considered as an alternative approach in the treatment of one to three metastatic lesions in selected patients. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
11. Deep brain stimulation and frameless stereotactic radiosurgery in the treatment of bilateral parkinsonian tremor: target selection and case report of two patients.
- Author
-
Franzini, Angelo, Marchetti, Marcello, Brait, Lorenzo, Milanesi, Ida, Messina, Giuseppe, Forapani, Elisabetta, Broggi, Giovanni, and Fariselli, Laura
- Subjects
- *
CASE studies , *PARKINSONIAN disorders , *BRAIN stimulation , *STEREOENCEPHALOTOMY , *RADIOSURGERY , *TARGETED drug delivery - Abstract
Considerable positive experience in functional radiosurgery has been reported since Leksell's first experience in 1951, but the development of frameless radiosurgery was been limited because of the difficulty of identifying invisible functional targets. In this paper we report on two cases of bilateral parkinsonian tremor successfully treated with DBS on one side and with frameless radiosurgery on the contralateral side. We focus on the methodology developed to define the three-dimensional target coordinates for frameless radiosurgery. Two patients suffering from a disabling upper-limb parkinsonian tremor underwent frameless radiosurgical thalamotomy. To accurately identify the treatment target the CT gantry was treated as a stereotactic frame; a rototranslation between the origin of the screen and the origin of the stereotactic atlas allowed us to obtain atlas-registered 3D coordinates of each point on the CT axial brain slices. Both patients achieved complete bilateral tremor control by unilateral radiosurgery and contralateral DBS. We developed a method for determining the 3D coordinates of a known functional target to treat with frameless radiosurgery. Based on the initial experiences, frameless radiosurgery appears to be an alternative treatment for Parkinsonian upper limb tremor in the presence of increased surgical risks for DBS placement. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
12. Paragangliomas of head and neck: a treatment option with CyberKnife radiosurgery.
- Author
-
Bianchi, Livia C., Marchetti, Marcello, Brait, Lorenzo, Bergantin, Achille, Milanesi, Ida, Broggi, Giovanni, and Fariselli, Laura
- Subjects
- *
PARAGANGLIOMA , *RADIOSURGERY , *TUMORS , *THERAPEUTIC embolization , *NEUROSCIENCES - Abstract
Paragangliomas are highly vascular and predominantly benign neoplasms that have traditionally been treated by surgery, embolization and/or external beam radiotherapy (EBRT). The aim of this study is to evaluate the short-term local tumor control and safety of CyberKnife radiosurgery for these lesions. Nine patients, eight with jugular glomus paragangliomas and one with a carotid body paraganglioma, were treated. The target contouring was performed on merged CT and MR images. Eight patients were treated with doses ranging from 11 to 13 Gy (mean 12.5 Gy) in a single fraction and one with 24 Gy in three fractions prescribed to 72–83% isodose line. The mean follow-up was 20 months. One patient died from unrelated causes. There were no local recurrences. All eight patients also demonstrated neurological stability or improvement. Neither cranial nerve palsies have arisen, nor has deterioration beyond baseline been observed. In conclusion, CyberKnife radiosurgery appears to be both safe and effective in the treatment of skull base paragangliomas. Determining whether long-term complications will arise will require further investigation. [ABSTRACT FROM AUTHOR]
- Published
- 2009
- Full Text
- View/download PDF
13. Penetration of orally administered prulifloxacin into human lung tissue.
- Author
-
Concia, Ercole, Allegranzi, Benedetta, Ciottoli, Giovanni B., Orticelli, Giovanna, Marchetti, Marcello, and Dionisio, Paolo
- Subjects
DRUG dosage ,LUNGS ,TISSUES ,CHROMATOGRAPHIC analysis ,LIQUID chromatography ,HEMOGLOBINS ,ANTI-infective agents ,COMPARATIVE studies ,HETEROCYCLIC compounds ,LUNG tumors ,RESEARCH methodology ,MEDICAL cooperation ,ORAL drug administration ,PNEUMONECTOMY ,QUINOLONE antibacterial agents ,RESEARCH ,EVALUATION research ,RANDOMIZED controlled trials - Abstract
Objective: To evaluate the distribution in lung tissue of ulifloxacin, the active metabolite of prulifloxacin, a new once-daily fluoroquinolone administered orally in a single 600mg dose.Design: Open-label, randomised study.Patients: Twenty-seven patients (25 males, 2 females; mean age 65.7 years [range 49-79 years]) with a lung neoplasm requiring lobectomy or pneumonectomy.Methods: Patients were randomly assigned to five treatment groups and received a single oral dose of prulifloxacin 600mg at 2, 4, 6, 12 or 24 hours preoperatively. During surgery, blood and healthy lung (based on macroscopic appearance) samples were collected at the same time. Ulifloxacin concentrations in plasma and lung tissue were determined by a validated reversed-phase high-performance liquid chromatography assay. Lung tissue ulifloxacin concentrations were adjusted for blood contamination, by measuring haemoglobin in the supernatant of each tissue sample and applying a corrective equation.Results: Ulifloxacin concentration in lung tissue exceeded plasma concentration at every timepoint. Following administration of prulifloxacin 600mg, the overall mean corrected lung/plasma ratio over the 24-hour period was 6.9 (range 1.2-14.1). When sampling intervals were assessed, the corrected lung/plasma ratios were 7.5 (2 hours after dosing), 6.3 (4 hours), 4.3 (6 hours), 7.0 (12 hours) and 9.2 (24 hours). The mean corrected lung/plasma area under the concentration-time curve ratio was 6.3, demonstrating the ability of the drug to penetrate lung tissue and confirming the high exposure of this target tissue to ulifloxacin. However, the limitation of the lung tissue sampling method and the high interpatient variability should be considered. Over the 24-hour period, the concentrations of ulifloxacin in lung tissue were higher than the minimum inhibitory concentration (MIC) values for pathogens frequently involved in community-acquired respiratory tract infections.Conclusion: Lung tissue penetration data may have a supportive value when considered jointly with MICs and efficacy results. The findings from this lung penetration study could explain the efficacy of once-daily prulifloxacin 600mg observed in clinical trials conducted in patients with exacerbation of chronic bronchitis. [ABSTRACT FROM AUTHOR]- Published
- 2005
- Full Text
- View/download PDF
14. Radiosurgical treatment of ulnar plexiform neurofibroma in a neurofibromatosis type 1 (NF1) patient.
- Author
-
Marchetti, Marcello, Franzini, Angelo, Nazzi, Vittoria, Martin, Elena, and Fariselli, Laura
- Subjects
- *
CASE studies , *NEUROFIBROMATOSIS 1 , *NEUROFIBROMA , *RADIOSURGERY , *ULNAR nerve , *MAGNETIC resonance imaging , *THERAPEUTICS - Abstract
The article presents a case study of a 50-year-old woman affected by neurofibromatosis type 1 (NF1) and treated with radiosurgery for an ulnar nerve plexiform neurofibroma (PNF). Neurological examination revealed a moderate hypoesthesia along the ulnar territory, a mild hypotrophy of the first left posterior interosseous muscle, and a left-hand motor impairment. In addition, a left ulnar nerve PNF was demonstrated by magnetic resonance imaging (MRI).
- Published
- 2013
- Full Text
- View/download PDF
15. Erratum to: Radiosurgery reirradiation for high-grade glioma recurrence: a retrospective analysis.
- Author
-
Pinzi, Valentina, Orsi, Chiara, Marchetti, Marcello, Milanesi, Ida, Bianchi, Livia, DiMeco, Francesco, Cuccarini, Valeria, Farinotti, Mariangela, Ferroli, Paolo, Finocchiaro, Gaetano, Franzini, Angelo, Fumagalli, MariaLuisa, Silvani, Antonio, and Fariselli, Laura
- Subjects
PUBLISHED errata ,RADIOSURGERY ,IRRADIATION ,GLIOMAS ,RETROSPECTIVE studies ,DISEASE risk factors - Published
- 2015
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.